Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre.

Abstract

In a long-term study in the largest published cohort of SLE patients, IVIG was found to be effective in selected manifestations such as haematological and cardiac involvement or when other therapeutic approaches are not available, such as in patients with active disease and concomitant infection.